Dudediligence.

Invivyd, Inc

IVVDNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price

From the filings

Figures

Revenue
$58.4Mlast 12 months
Net income
−$107.3Mlast 12 months
Operating cash flow
−$78.7Mlast 12 months
Cash and equivalents
$160.1Mat the last balance sheet
Shares outstanding
294.8M shareson issue
Every year and quarter →